Diasorin SpA (STU:34D) Short Interest


STU:34D Diasorin SpA STU:34D
73 GF Score
Price €68.18
GF Value €89.87
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Diasorin SpA Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

STU:34D vs TMO, DHR, IDXX: Short Interest Comparison

For the Diagnostics & Research subindustry, Diasorin SpA's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Diasorin SpA Short Interest vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Diasorin SpA's Short Interest distribution charts can be found below:

* The bar in red indicates where Diasorin SpA's Short Interest falls into.


STU:34D
73GF Score
Diasorin SpA STU:34D
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Diasorin SpA (STU:34D) Overvalued in 2026?

Based on GuruFocus' analysis, Diasorin SpA stock appears to be undervalued. The current stock price of €68.18 is trading 24.1% below its estimated GF Value™ of €89.87. GuruFocus considers Diasorin SpA to be Modestly Undervalued.

Key valuation signals for STU:34D:

  • Short Interest:
  • GF Value™: €89.87 vs. price of €68.18 (24.1% below fair value)
  • GF Score™: 73/100 with 5 warning signs

No single metric tells the full story. See the STU:34D stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Diasorin SpA Business Description

Address Via Crescentino Snc, Saluggia, Vercelli, ITA, 13040
Diasorin develops and manufactures a broad portfolio of in vitro diagnostics for detecting pathogens and sample contamination from the human body, as well as for use in industrial settings, such as food and water contamination testing. The company operates three segments: immunodiagnostics (69% of sales), molecular diagnostics (16%), and licensed technologies (14%). Diasorin was an important manufacturer of covid tests, which boosted its profits during the pandemic, but this segment's importance has decreased over the years, and in 2025, it accounted for only 1% of total sales.
73GF Score

Get the complete analysis for STU:34D

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€68.18
Price
€89.87
GF Value